ainewsblitz.com

Breaking

Dognosis starts 10,000-person India trial of dog-and-AI breath cancer screen after ~90% Phase 2 sensitivity

Dognosis starts 10,000-person India trial of dog-and-AI breath cancer screen after ~90% Phase 2 sensitivity
  • Healthcare
  • Research & Papers

Bengaluru-based Dognosis has begun a roughly 10,000-person Phase 3 trial of a breath test that uses trained detection dogs plus machine-learning analysis of their reactions, after a Phase 2 study reported about 90% sensitivity for early-stage cancers. The larger study is running across 10 hospitals in India over about 12 months, ahead of a planned 2027 launch of an at-home prescreening product called BreathEasy.

Continue reading

The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.

$20
Read this article
$29/month
Unlimited — all 27,694 articles, the full archive, and comprehension quizzes
Save 72%
$98/year
≈ $8.17/month
Unlimited, billed once a year